G3BP2-KIT drives leukemia amenable to kinase inhibition in Ph-like ALL.

G3BP2-KIT drives leukemia amenable to kinase inhibition in Ph-like ALL.
复制标题

DOI:
10.1182/bloodadvances.2021004854
复制
发表时间:
2022-06-14
期刊:
影响因子:
7.5
通讯作者:
Mullighan, Charles G.
Mullighan, Charles G.
中科院分区:
医学1区
文献类型:
--
作者:
Iacobucci, Ilaria;Fukano, Reiji;Friske, Jake D.;Qu, Chunxu;Janke, Laura J.;Zhao, Yaqi;Baviskar, Pradyuamna;Backhaus, Emily A.;Chockley, Peter;Seth, Aman;Laird, A. Douglas;Advani, Anjali S.;Mullighan, Charles G.

文献摘要

参考文献

相似文献

""
DOI: 10.1016/j.ccr.2012.06.005
发表时间: 2012-08-14
期刊: Cancer cell
影响因子: 50.3
作者:
Roberts KG;Morin RD;Zhang J;Hirst M;Zhao Y;Su X;Chen SC;Payne-Turner D;Churchman ML;Harvey RC;Chen X;Kasap C;Yan C;Becksfort J;Finney RP;Teachey DT;Maude SL;Tse K;Moore R;Jones S;Mungall K;Birol I;Edmonson MN;Hu Y;Buetow KE;Chen IM;Carroll WL;Wei L;Ma J;Kleppe M;Levine RL;Garcia-Manero G;Larsen E;Shah NP;Devidas M;Reaman G;Smith M;Paugh SW;Evans WE;Grupp SA;Jeha S;Pui CH;Gerhard DS;Downing JR;Willman CL;Loh M;Hunger SP;Marra MA;Mullighan CG
通讯作者: Mullighan CG
DOI: 10.1016/s1470-2045(08)70339-5
发表时间: 2009-02
期刊: LANCET ONCOLOGY
影响因子: 51.1
作者:
Den Boer, Monique L.;van Slegtenhorst, Marjon;De Menezes, Renee X.;Cheok, Meyling H.;Buijs-Gladdines, Jessica G. C. A. M.;Peters, Susan T. C. J. M.;Van Zutven, Laura C. M.;Beverloo, H. Berna;Van der Spek, Peter J.;Escherich, Gaby;Horstmann, Martin A.;Janka-Schoub, Gritta E.;Kamps, Willem A.;Evans, William E.;Pieters, Rob
通讯作者: Pieters, Rob
DOI: 10.1200/jco.2016.69.0073
发表时间: 2017-02-01
影响因子: 45.3
作者:
Roberts, Kathryn G.;Gu, Zhaohui;Mullighan, Charles G.
通讯作者: Mullighan, Charles G.
DOI: 10.1182/bloodadvances.2019001182
发表时间: 2020-02-11
期刊: BLOOD ADVANCES
影响因子: 7.5
作者:
Jan, Max;Grinshpun, Daniel E.;Nardi, Valentina
通讯作者: Nardi, Valentina
DOI: 10.2147/dddt.s89114
发表时间: 2016
期刊: Drug design, development and therapy
影响因子: --
作者:
Abbaspour Babaei M;Kamalidehghan B;Saleem M;Huri HZ;Ahmadipour F
通讯作者: Ahmadipour F